Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy
IGA Glomerulonephritis
About this trial
This is an interventional diagnostic trial for IGA Glomerulonephritis focused on measuring IGA Glomerulonephritis, Autonomic nervous system, ANS
Eligibility Criteria
Inclusion Criteria:
- diagnosis of IgNA biopsy-proven free, informed, express and written
Exclusion Criteria:
- IgNA secondary to Henoch-Schonlein purpura (HSP) or Systemic Lupus Erythematosus or alcoholic cirrhosis
- current kidney transplantation
- Hypertension treated or not,
- Diseases interfering with ANS analysis: cardiac arrhythmia, beta-blocker therapy
- diabetes
Sites / Locations
- CHU Saint-Etienne
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Experimental
Experimental
Experimental
Experimental
Experimental
IgAN with glomerular filtration rate (GFR) >90 ml/min/1.73 m2
IgAN with GFR 60-89 ml/min/1.73 m2
IgAN with GFR 30-59 ml/min/1.73 m2
IgAN with GFR 15-29 ml/min/1.73 m2
IgAN with GFR < 15ml/min/1.73 m2
Measure of ANS by holter device in IgAN patients with glomerular filtration rate (GFR) >90 ml/min/1.73 m2
Measure of ANS by holter device in IgAN patients with GFR 60-89 ml/min/1.73 m2
Measure of ANS by holter device in IgAN patients with GFR 30-59 ml/min/1.73 m2
Measure of ANS by holter device in IgAN patients with GFR 15-29 ml/min/1.73 m2
Measure of ANS by holter device in IgAN patients with GFR < 15ml/min/1.73 m2.